Organogenesis Holdings Inc - Class A
Research Organogenesis Holdings Inc - Class A (ORGO) on Bullrun: market cap USD 223.89M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerORGO
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 223.89M
- Financial periodQ2 2026
- RevenueUSD 42.81M
- Net income-USD 96.27M
- Free cash flow-USD 32.75M
- Gross margin44.7%
Valuation Snapshot
latest market cap is USD 223.89M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 564.17M | USD 37.00M | -USD 24.46M | 75.4% | 0.15 | USD 93.68M | USD 82.14M | USD 300.13M |
| FY2024 | USD 482.04M | USD 900.00K | USD 4.18M | 76.0% | -0.01 | USD 135.57M | USD 43.31M | USD 262.90M |
| FY2023 | USD 433.14M | USD 4.90M | USD 6.55M | 75.4% | 0.04 | USD 103.84M | USD 66.56M | USD 278.66M |
| FY2022 | USD 450.89M | USD 15.50M | -USD 9.04M | 76.7% | 0.12 | USD 102.48M | USD 71.25M | USD 265.67M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 223.89M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 657.61M | 47.1 | n/a | n/a |
| 2024 | 2024-12-31 | USD 402.34M | 320.0 | n/a | n/a |
| 2023 | 2023-12-29 | USD 537.07M | 40.9 | n/a | n/a |
| 2022 | 2022-12-30 | USD 352.16M | 6.1 | n/a | n/a |
| 2021 | 2021-12-31 | USD 1.19B | 13.0 | n/a | n/a |
About Organogenesis Holdings Inc - Class A
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States. Its advanced wound care products include Affinity and Novachor, which are amnion and chorion placental allografts for use in the care of chronic and acute wounds as protective barriers and extracellular matrix (ECM) scaffolds;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Organogenesis Holdings Inc - Class A's market cap?
Organogenesis Holdings Inc - Class A's market capitalization is USD 223.89M.
What does Organogenesis Holdings Inc - Class A do?
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.